Catalyst Pharmaceuticals
Recent Data Breaches and Security Report

https://catalystpharma.com  ᛫ 
Last updated October 26, 2018

Company Details

Company Overview

Catalyst Pharmaceuticals is a biopharmaceutical company based in Coral Gables, Florida. The company is developing therapeutics for rare neurological diseases, including the phosphate salt of amifampridine for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) under the trade name "Firdapse", and CPP-115 (a GABA transaminase) for the treatment of infantile spasms.

Valuation

Employees

CEO

Location

Recent Data Breaches

Stay informed about the most recent data breaches affecting companies like Catalyst Pharmaceuticals

subscribe to data breach notifications

Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more effective a company is in implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Catalyst Pharmaceuticals

Get full security report ›

See UpGuard In Action

Book a demo with one of our cybersecurity specialists.